FIELD: chemico-pharmaceutical industry.
SUBSTANCE: mixture A obtained due to mixing pre-reduced acetylsalicylic acid with a carrier and glucose followed by its diluting in aqueous-alcoholic solution should be mixed with mixture B obtained due to suspending calcium gluconate, plastifying and lipophilic agents in solvent, followed by deaeration of the mixture obtained, its application onto bottom plate with subsequent drying and forming the ready-to-use medicinal form. Method enables to obtain remedy of increased stability of functional characteristics, prolonged action and increased bioavailability of acetylsalicylic acid at no side effects.
EFFECT: higher efficiency.
3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR PLATELET AGGREGATION DECREASE IN CIRCULATORY SYSTEM | 1995 |
|
RU2095064C1 |
AGENT FOR FLUORESCENT DIAGNOSIS AND PHOTODYNAMIC THERAPY ON ONCOLOGICAL AND NON-ONCOLOGICAL DISEASES | 2002 |
|
RU2219921C1 |
DICALCIUM SALT OF N-(3-HYDROXYBENZOYL)TAURINE, HAVING ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY IN COMBINATION WITH CEREBROPROTECTIVE ACTION | 2019 |
|
RU2730835C1 |
AGENT SHOWING ANTIAGGREGATION ACTIVITY | 1991 |
|
RU2061481C1 |
METHOD FOR OBTAINING PLANT AGENT WITH BIOLOGICAL ACTIVITY | 2022 |
|
RU2785678C1 |
PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
METHOD OF PREPARING ANTI-INFLAMMATORY ANALGETIC AGENT | 1998 |
|
RU2173555C2 |
COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
METHOD FOR PRODUCING OPHTHALMIC FILMS | 2004 |
|
RU2314793C2 |
METHOD OF SYNTHESIS OF CALCIUM GLUCONATE | 1996 |
|
RU2118955C1 |
Authors
Dates
2005-05-27—Published
2004-02-17—Filed